Theravance Biopharma Inc. (TBPH) tumbled -5.64% or -1.56 to $26.09. It is around 211719 shares traded, which is 90.18% compare to the average total volume 234771. The market cap of TBPH is $1.42 billion. The year to date change is -1.5%. The 52 week price range is from $22.9 to $43.44. Price of TBPH have changed 5.82% during last week. It have changed 2.26% over last month, 0.00% over last 3 months, -17.44% over last 6 months and -15.60% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TBPH is 27.68. It is 6.09% above current price. The 200-day Moving Averages for TBPH is 30.99. It is 18.78% above current price. The 52-week High is 43.44. It is 66.50% from the current price. The 52-week Low is 22.9. It is -12.23% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of TBPH is 19.12 on 2018-02-28. Short % to float is 11.90%. There are some statistics of TBPH. It is has market cap $1.42 billion. The share outstanding is 54.38 million. The average volume is 234771. The revenue is 10.87M. The gross profit is 7.96M. The percent of top 15 Institution holding is 75.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TBPH is -122.65%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TBPH is -52.82%.